Effects of arsenite on p53, p21 and cyclin D expression in normal human fibroblasts - A possible mechanism for arsenite's comutagenicity

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 478, Issue 1-2, 2001, Pages 159-168

  Vogt, Barbara L ^a   Rossman, Toby G ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arsenic; Comutagenesis; Cyclin D; Fibroblasts; p21; p53

Indexed keywords

ARSENIC TRIOXIDE; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CYCLIN D; PROTEIN P21; PROTEIN P53;

ARTICLE; CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; GENOTOXICITY; HUMAN; HUMAN CELL; IONIZING RADIATION; LONG TERM EXPOSURE; LUNG FIBROBLAST; MUTAGENICITY; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ARSENITES; CELL LINE; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; HUMANS; IMMUNOBLOTTING; LETHAL DOSE 50; MUTAGENICITY TESTS; MUTAGENS; PROTEINS; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 0035400489     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(01)00137-3     Document Type: Article

References (79)

1. The relationship of arsenic levels in drinking water and the prevalence rate of skin lesions in Bangladesh
2. Molecular and genetic toxicology of arsenic
3. The effects of ingested arsenic exposure on methyl cholanthrene induced skin tumours in mice
4. Arsenic can mediate skin neoplasia by chronic stimulation of keratinocyte-derived growth factors
5. Synergism between occupational arsenic exposure and smoking in the induction of lung cancer
6. On the interaction between occupational arsenic exposure and smoking and its relationship to lung cancer
7. A cohort study in southern China of tin miners exposed to radon and radon decay products
8. Sodium arsenite enhances the cytotoxicity clastogenicity and 6-thioguanine-resistant mutagenicity of ultraviolet light in Chinese hamster ovary cells
9. Mechanism of comutagenesis of sodium arsenite with N-methyl-N-nitrosourea
10. Comutagenesis of sodium arsenite with ultraviolet radiation in Chinese hamster V79 cells
11. Specificity of arsenite in potentiating cytogenetic damage induced by the DNA crosslinking agent diepoxybutane
12. Genotoxic effects of sodium arsenite on human cells
13. Inhibition of DNA ligase activity by arsenite - A possible mechanism of its comutagenesis
14. Arsenic toxicity is enzyme specific and its affects on ligation are not caused by the direct inhibition of DNA repair enzymes
15. Inhibition of human excision DNA repair by inorganic arsenic and the comutagenic effect in V79 Chinese hamster cells
16. Interaction of arsenic-(III) with nucleotide excision repair in UV-irradiated human fibroblasts
17. Effect of arsenic and cadmium on the persistence of mutagen-induced DNA lesions in human cells
18. Induction of chromatid breaks and tetraploidy in Chinese hamster ovary cells by treatment with sodium arsenite during the G2 phase
19. Comparison of arsenic-induced cell transformation, cytotoxicity, mutation and cytogenetic effects in Syrian hamster embryo cells in culture
20. Differential susceptibility to carcinogen-induced amplification of SV40 and dhfr sequences in SV40-transformed human keratinocytes
21. Effects of exposure protocols on induction of kinetochore plus and -minus micronuclei by arsenite in diploid human fibroblasts
22. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
23. Arsenite genotoxicity may be mediated by interference with DNA damage-inducible signaling
24. p53, the cellular gatekeeper for growth and division
25. The complexity of p53 modulation - Emerging patterns from divergent signals
26. The p53 pathway
27. Regulation of p53 stability and activity in response to genotoxic stress
28. p21/p53, cellular growth control and genomic integrity
29. p21-negative regulator of the cell cycle
30. Failla memorial lecture: Changing views of radiosensitivity
31. Long-term genome stability and minimal genotypic and phenotypic alterations in HPV16 E7-, but not E6-immortalized human uroepithelial cells
32. p53 inactivation by HPV16 E6 results in increased mutagenesis in human cells
33. Participation of p53 protein in the cellular response to DNA damage
34. Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols
35. Monomethylarsonous acid (MMIII) is more toxic than arsenite in chang human hepatocytes
36. Cellular uptake and metabolic reduction of pentavalent to trivalent arsenic as determinants of cytotoxicity and morphological transformation
37. Efflux mediated resistance to arsenicals in arsenic resistant and -hypersensitive Chinese hamster cells
38. Induction of p53 protein expression by sodium arsenite
39. DNA damage in arsenite- and cadmium-treated bovine aortic endothelial cells
40. Arsenite stimulates poly(ADP-ribosylation) by generation of nitric oxide
41. DNA damage and mutation in human cells exposed to nitric oxide in vitro
42. EPR characterization of molecular targets for NO in mammalian cells and organelles
43. Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinioma cells by a nitric oxide-dependent mechanism
44. Nitric oxide inhibits DNA ligase activity: Potential mechanisms for NO-mediated DNA damage
45. Induction of p53 and p21/WAF1/CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells
46. Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein
47. Arsenite inhibits two steps in the ubiquitin-dependent proteolytic pathway
48. Stimulation of reactive oxygen, but not reactive nitrogen species, in vascular endothelial cells exposed to low levels of arsenite
49. Low levels of arsenic trioxide stimulate proliferative signals in primary vascular cells without activating stress effect or pathways
50. Requirement of Erk, but not JNK, for arsenite-induced cell transformation
51. Mechanisms of switching on p53: A role for covalent modification?
52. Induction of oncogene expression by sodium arsenite in C3H/10T1/2 cells: Inhibition of c-myc expression by the Bowman-Birk protease inhibitor
53. Molecular mechanisms of transformation of C3H/10T1/2 C1 8 mouse embryo cells and diploid human fibroblasts by carcinogenic metal compounds
54. Effect of glutathione depletion and metallothionein gene expression on arsenic-induced cytotoxicity and c-myc expression in vitro
55. Enhanced transcription factor DNA binding and gene expression induced by arsenite or arsenate in renal slices
56. Sodium arsenite-induced dysregulation of proteins involved in proliferative signaling
57. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
58. Overexpression of c-Myc inhibits p21WAF1/CIP1 expression and induces S-phase entry in 12-0-tetradecanoylphorbol-13-acetate (TPA)-sensitive human cancer cells
59. Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27
60. Modulation of p53 protein conformation and DNA-binding activity by intracellular chelation of zinc
61. Redox modulation of p53 conformation and sequence-specific DNA finding in vitro
62. Cadmium induces conformational modifications of wild-type p53 and suppresses p53 response to DNA damage in cultured cells
63. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells
64. Methylarsenicals and arsinothiols are potent inhibitors of mouse liver thioredoxin reductase
65. Thioredoxin-dependent redox regulation of p53-mediated p21 activation
66. The tumor suppressor protein p53: A receptor to genotoxic stress that controls cell growth and survival
67. Human fibroblasts expressing the human papillomavirus E6 gene are deficient in global genomic nucleotide excision repair and sensitive to ultraviolet irradiation
68. The dual role model for p53 in maintaining genomic integrity
69. Abrogation of p53 function by HPV16 E6 gene delays apoptosis and enhances mutagenesis but does not alter radiosensitivity in TK6 human lymphoblast cells
70. The hallmarks of cancer
71. New functional activities for the p21 family of CDK inhibitors
72. Repair defect in p21/WAFI/CIPI-/- human cancer cells
73. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21
74. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced GI arrest
75. Functional role of p21 during the cellular response to stress
76. HuR regulates p21 mRNA stabilization by UV light